<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">antibiotics</journal-id><journal-title-group><journal-title xml:lang="ru">Антибиотики и Химиотерапия</journal-title><trans-title-group xml:lang="en"><trans-title>Antibiot Khimioter = Antibiotics and Chemotherapy</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0235-2990</issn><publisher><publisher-name>ООО «Издательство ОКИ»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">antibiotics-87</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LECTURES</subject></subj-group></article-categories><title-group><article-title>А-стрептококковые инфекции глотки: диагностика и рациональная антибактериальная терапия</article-title><trans-title-group xml:lang="en"><trans-title>Group A Streptococcal Pharyngeal Infections: Diagnosis and Rational Antibacterial Therapy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белов</surname><given-names>Б. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Belov</surname><given-names>B. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ ревматологии им. В. А. Насоновой</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V. A. Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>06</day><month>05</month><year>2020</year></pub-date><volume>63</volume><issue>5-6</issue><fpage>68</fpage><lpage>75</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; ООО «Издательство ОКИ», 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">ООО «Издательство ОКИ»</copyright-holder><copyright-holder xml:lang="en">ООО «Издательство ОКИ»</copyright-holder><license xlink:href="https://www.antibiotics-chemotherapy.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.antibiotics-chemotherapy.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.antibiotics-chemotherapy.ru/jour/article/view/87">https://www.antibiotics-chemotherapy.ru/jour/article/view/87</self-uri><abstract><p>Проблема острого тонзиллита, вызванного бета-гемолитическим стрептококком группы А (БГСА), по-прежнему сохраняет свою актуальность как во врачебном, так и в общемедицинском плане. В настоящей статье представлены данные, свидетельствующие о возрождении высоковирулентной БГСА-инфекции и нарастании частоты осложнений (острая ревматическая лихорадка, синдром токсического шока), обоснована необходимость рациональной антибактериальной терапии данной патологии. Препаратами выбора для лечения острых форм БГСА-тонзиллита являются пенициллины и цефалоспорины I поколения, а при непереносимости бета-лактамных антибиотиков - макролиды. При наличии хронического рецидивирующего БГСА-тонзиллита, когда вероятность колонизации очага инфекции микроорганизмами, продуцирующими бета-лактамазы, достаточно высока, применяют ингибиторозащищённые пенициллины или цефалоспорины II-III поколения. Антибиотики - линкозамиды используют в терапии острого и хронического БГСА-тонзиллита как препараты резерва.</p></abstract><trans-abstract xml:lang="en"><p>The problem of acute tonsillitis caused by Group A Beta-Hemolytic Streptococcus (GABHS) still remains relevant. This article provides data showing the revival of highly virulent GABHS infection and an increase in the incidence of complications (acute rheumatic fever, toxic shock syndrome), and substantiates the need for rational antibiotic therapy of this pathology. The drugs of choice for the treatment of acute forms of GABHS tonsillitis are penicillins and cephalosporins of the first generation, and macrolides in case of intolerance to beta-lactam antibiotics. In the presence of chronic relapsing GABHS tonsillitis, when the probability of colonization of the source of infection by microorganisms producing beta-lactamases is high enough, inhibitor-protected penicillins or cephalosporins of II-III generation are used. Lincosamide antibiotics are used in the treatment of acute and chronic GABHS tonsillitis as reserve drugs.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Ключевье слова: А-стрептококковый тонзиллит</kwd><kwd>антибиотикотерапия</kwd><kwd>пенициллины</kwd><kwd>макролиды</kwd><kwd>линкозамиды</kwd></kwd-group><kwd-group xml:lang="en"><kwd>group A streptococcal tonsillitis</kwd><kwd>antibiotic therapy</kwd><kwd>penicillins</kwd><kwd>macrolides</kwd><kwd>lincosamides</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Gerber M.A., Baltimore R.S., Eaton C.B., Gewitz M., Rowley A.H., Shulman S.T., Taubert K.A. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009;119 (11): 1541-1551.</mixed-citation><mixed-citation xml:lang="en">Gerber M.A., Baltimore R.S., Eaton C.B., Gewitz M., Rowley A.H., Shulman S.T., Taubert K.A. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009;119 (11): 1541-1551.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Shulman S.T., Bisno A.L., Clegg H.W., Gerber M.A., Kaplan E.L., Lee G. et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis 2012; 55 (10): e86-102.</mixed-citation><mixed-citation xml:lang="en">Shulman S.T., Bisno A.L., Clegg H.W., Gerber M.A., Kaplan E.L., Lee G. et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis 2012; 55 (10): e86-102.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Long A., Lungu J.C., Machila E., Schwaninger S., Spector J., Tadmor B. et al. A programme to increase appropriate usage of benzathine penicillin for management of streptococcal pharyngitis and rheumatic heart disease in Zambia. Cardiovasc J Afr 2017; 28 (4): 242-247.</mixed-citation><mixed-citation xml:lang="en">Long A., Lungu J.C., Machila E., Schwaninger S., Spector J., Tadmor B. et al. A programme to increase appropriate usage of benzathine penicillin for management of streptococcal pharyngitis and rheumatic heart disease in Zambia. Cardiovasc J Afr 2017; 28 (4): 242-247.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Насонова B.A., Белов Б.С., Страчунский Л.С., Каманин Е.И., Богданович Т.М., Судиловская H.H., Кречикова О.И., Богомильский М.Р., Овчинников Ю.М. Антибактериальная терапия стрептококкового тонзиллита и фарингита. Клин. микробиол. антимикроб. тер. - 1999. - № 1. - С. 78-82.</mixed-citation><mixed-citation xml:lang="en">Насонова B.A., Белов Б.С., Страчунский Л.С., Каманин Е.И., Богданович Т.М., Судиловская H.H., Кречикова О.И., Богомильский М.Р., Овчинников Ю.М. Антибактериальная терапия стрептококкового тонзиллита и фарингита. Клин. микробиол. антимикроб. тер. - 1999. - № 1. - С. 78-82.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Wannamaker L.W. Perplexity and precision in the diagnosis of streptococcal pharyngitis. Am J Dis Child 1972; 124: 352-358.</mixed-citation><mixed-citation xml:lang="en">Wannamaker L.W. Perplexity and precision in the diagnosis of streptococcal pharyngitis. Am J Dis Child 1972; 124: 352-358.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Pfoh E., Wessels M.R., Goldmann D., Lee G.M. Burden and economic cost of group A streptococcal pharyngitis. Pediatrics 2008; 121 (2): 229-234.</mixed-citation><mixed-citation xml:lang="en">Pfoh E., Wessels M.R., Goldmann D., Lee G.M. Burden and economic cost of group A streptococcal pharyngitis. Pediatrics 2008; 121 (2): 229-234.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Беляков В.Д. Сюрпризы стрептококковой инфекции. Вестн. РАМН. - 1996. - № 11. - С. 24-28.</mixed-citation><mixed-citation xml:lang="en">Беляков В.Д. Сюрпризы стрептококковой инфекции. Вестн. РАМН. - 1996. - № 11. - С. 24-28.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Breda L., Miulli E., Marzetti V., Chiarelli F., Marcovecchio M.L. Rheumatic fever: a disease still to be kept in mind. Rheumatology (Oxford) 2013 May; 52 (5): 953.</mixed-citation><mixed-citation xml:lang="en">Breda L., Miulli E., Marzetti V., Chiarelli F., Marcovecchio M.L. Rheumatic fever: a disease still to be kept in mind. Rheumatology (Oxford) 2013 May; 52 (5): 953.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Vinker S., Zohar E., Hoffman R., Elhayany A. Incidence and clinical manifestations of rheumatic fever: a 6 year community-based survey. Isr Med Assoc J 2010; 12 (2): 78-81.</mixed-citation><mixed-citation xml:lang="en">Vinker S., Zohar E., Hoffman R., Elhayany A. Incidence and clinical manifestations of rheumatic fever: a 6 year community-based survey. Isr Med Assoc J 2010; 12 (2): 78-81.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kocevar U., Toplak N., Kosmac B., Kopac L., Vesel S., Krajnc N. et al. Acute rheumatic fever outbreak in southern central European country. Eur J Pediatr 2017 Jan; 176 (1): 23-29.</mixed-citation><mixed-citation xml:lang="en">Kocevar U., Toplak N., Kosmac B., Kopac L., Vesel S., Krajnc N. et al. Acute rheumatic fever outbreak in southern central European country. Eur J Pediatr 2017 Jan; 176 (1): 23-29.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Noonan S., Zurynski Y.A., Currie B.J, McDonald M., Wheaton G., Nissen M. et al. A national prospective surveillance study of acute rheumatic fever in Australian children. Pediatr Infect Dis J 2013 Jan; 32 (1): e26-32.</mixed-citation><mixed-citation xml:lang="en">Noonan S., Zurynski Y.A., Currie B.J, McDonald M., Wheaton G., Nissen M. et al. A national prospective surveillance study of acute rheumatic fever in Australian children. Pediatr Infect Dis J 2013 Jan; 32 (1): e26-32.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">McIsaac W.J., Goel V., To T., Low D.E. The validity of a sore throat score in family practice. CMAJ 2000; 163 (7): 811-815.</mixed-citation><mixed-citation xml:lang="en">McIsaac W.J., Goel V., To T., Low D.E. The validity of a sore throat score in family practice. CMAJ 2000; 163 (7): 811-815.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Regoli M., Chiappini E., Bonsignori F., Galli L., de Martino M. Update on the management of acute pharyngitis in children. Ital J Pediatr 2011 Jan 31; 37: 10.</mixed-citation><mixed-citation xml:lang="en">Regoli M., Chiappini E., Bonsignori F., Galli L., de Martino M. Update on the management of acute pharyngitis in children. Ital J Pediatr 2011 Jan 31; 37: 10.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chiappini E., Regoli M., Bonsignori F., Sollai S., Parretti A., Galli L., de Martino M. Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther 2011; 33 (1): 48-58.</mixed-citation><mixed-citation xml:lang="en">Chiappini E., Regoli M., Bonsignori F., Sollai S., Parretti A., Galli L., de Martino M. Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther 2011; 33 (1): 48-58.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Chovel-Sella A., Ben Tov A., Lahav E., Mor O., Rudich H., Paret G., Reif S. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics 2013; 131 (5): e1424-427.</mixed-citation><mixed-citation xml:lang="en">Chovel-Sella A., Ben Tov A., Lahav E., Mor O., Rudich H., Paret G., Reif S. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics 2013; 131 (5): e1424-427.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Casey J.R., Pichichero M.E. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis. Clin Infect Dis 2005; 40 (12): 1748-1755.</mixed-citation><mixed-citation xml:lang="en">Casey J.R., Pichichero M.E. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis. Clin Infect Dis 2005; 40 (12): 1748-1755.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Altamimi S., Khalil A., Khalaiwi K.A., Milner R., Pusic M.V., Al Othman M.A. Short versus standard duration antibiotic therapy for acute streptococcal pharyngitis in children. Cochrane Database Syst Rev 2009; 1:CD004872.</mixed-citation><mixed-citation xml:lang="en">Altamimi S., Khalil A., Khalaiwi K.A., Milner R., Pusic M.V., Al Othman M.A. Short versus standard duration antibiotic therapy for acute streptococcal pharyngitis in children. Cochrane Database Syst Rev 2009; 1:CD004872.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Munck H., Jorgensen A. W., Klug T.E. Antibiotics for recurrent acute pharyngo-tonsillitis: systematic review. Eur J Clin Microbiol Infect Dis 2018 Apr 13. doi: 10.1007/s10096-018-3245-3.</mixed-citation><mixed-citation xml:lang="en">Munck H., Jorgensen A. W., Klug T.E. Antibiotics for recurrent acute pharyngo-tonsillitis: systematic review. Eur J Clin Microbiol Infect Dis 2018 Apr 13. doi: 10.1007/s10096-018-3245-3.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kaplan E.L., Chhatwal G.S., Rohde M. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis 2006; 43 (11): 1398-1406.</mixed-citation><mixed-citation xml:lang="en">Kaplan E.L., Chhatwal G.S., Rohde M. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis 2006; 43 (11): 1398-1406.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Fiedler T., Köller T., Kreikemeyer B. Streptococcus pyogenes biofilms - formation, biology, and clinical relevance. Front Cell Infect Microbiol Published online: 11 February 2015.</mixed-citation><mixed-citation xml:lang="en">Fiedler T., Köller T., Kreikemeyer B. Streptococcus pyogenes biofilms - formation, biology, and clinical relevance. Front Cell Infect Microbiol Published online: 11 February 2015.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Shen Y., Köller T., Kreikemeyer B., Nelson D.C. Rapid degradation of Streptococcus pyogenes biofilms by PlyC, a bacteriophage-encoded endolysin. J Antimicrob Chemother 2013; 68 (8): 1818-1824.</mixed-citation><mixed-citation xml:lang="en">Shen Y., Köller T., Kreikemeyer B., Nelson D.C. Rapid degradation of Streptococcus pyogenes biofilms by PlyC, a bacteriophage-encoded endolysin. J Antimicrob Chemother 2013; 68 (8): 1818-1824.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Азитромицин и биоплёнки. Данные на сайте: www.antibiotic.ru/ forum.php? t=930 / Azitromitsin i bioplyonki. Dannye na sajte: www.antibiotic.ru/forum.php? t=930</mixed-citation><mixed-citation xml:lang="en">Азитромицин и биоплёнки. Данные на сайте: www.antibiotic.ru/ forum.php? t=930 / Azitromitsin i bioplyonki. Dannye na sajte: www.antibiotic.ru/forum.php? t=930</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Азовскова О.В., Иванчик H.B., Дехнич A.B., Кречикова О.И., Козлов Р.С., исследовательская группа «ПеГАС». Динамика антибиотикорезистентности респираторных штаммов Streptococcus pyogenes в России за период 1999-2009 гг. Клин микробиол антимикроб химиотер. - 2012. - Т. 14. - № 4. - С. 309-321</mixed-citation><mixed-citation xml:lang="en">Азовскова О.В., Иванчик H.B., Дехнич A.B., Кречикова О.И., Козлов Р.С., исследовательская группа «ПеГАС». Динамика антибиотикорезистентности респираторных штаммов Streptococcus pyogenes в России за период 1999-2009 гг. Клин микробиол антимикроб химиотер. - 2012. - Т. 14. - № 4. - С. 309-321</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Logan L.K., McAuley J.B., Shulman S.T. Macrolide treatment failure in streptococcal pharyngitis resulting in acute rheumatic fever. Pediatrics 2012; 129 (3): e798-802.</mixed-citation><mixed-citation xml:lang="en">Logan L.K., McAuley J.B., Shulman S.T. Macrolide treatment failure in streptococcal pharyngitis resulting in acute rheumatic fever. Pediatrics 2012; 129 (3): e798-802.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Gerber M.A., Brown H.W., Lee G., Tanz R.R., Temte J.L., Van Beneden C.A. Physicians' opinions about critical attributes of a potential group A streptococcal vaccine. Vaccine 2010; 28 (44): 7155-7160.</mixed-citation><mixed-citation xml:lang="en">Gerber M.A., Brown H.W., Lee G., Tanz R.R., Temte J.L., Van Beneden C.A. Physicians' opinions about critical attributes of a potential group A streptococcal vaccine. Vaccine 2010; 28 (44): 7155-7160.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Tandon R. Preventing rheumatic fever: M-protein based vaccine. Indian Heart J. 2014 Jan-Feb; 66 (1): 64-67.</mixed-citation><mixed-citation xml:lang="en">Tandon R. Preventing rheumatic fever: M-protein based vaccine. Indian Heart J. 2014 Jan-Feb; 66 (1): 64-67.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
